Your browser doesn't support javascript.
loading
AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR.
Carlson, Cathrine R; Aronsen, Jan Magnus; Bergan-Dahl, Anna; Moutty, Marie Christine; Lunde, Marianne; Lunde, Per Kristian; Jarstadmarken, Hilde; Wanichawan, Pimthanya; Pereira, Laetitia; Kolstad, Terje R S; Dalhus, Bjørn; Subramanian, Hariharan; Hille, Susanne; Christensen, Geir; Müller, Oliver J; Nikolaev, Viacheslav; Bers, Donald M; Sjaastad, Ivar; Shen, Xin; Louch, William E; Klussmann, Enno; Sejersted, Ole M.
Afiliação
  • Carlson CR; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Aronsen JM; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Bergan-Dahl A; Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo Norway (J.M.A.).
  • Moutty MC; Department of Pharmacology, Oslo University Hospital, Norway (J.M.A.).
  • Lunde M; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Lunde PK; The KG Jebsen Cardiac Research Center, University of Oslo, Norway (A.B.-D., M.L., P.K.L., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Jarstadmarken H; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (M.C.M., E.K.).
  • Wanichawan P; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Pereira L; The KG Jebsen Cardiac Research Center, University of Oslo, Norway (A.B.-D., M.L., P.K.L., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Kolstad TRS; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Dalhus B; The KG Jebsen Cardiac Research Center, University of Oslo, Norway (A.B.-D., M.L., P.K.L., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Subramanian H; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Hille S; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Christensen G; Department of Pharmacology, University of California at Davis (L.P., D.M.B.).
  • Müller OJ; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (C.R.C., J.M.A., A.B.-D., M.L., P.K.L., H.J., P.W., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Nikolaev V; The KG Jebsen Cardiac Research Center, University of Oslo, Norway (A.B.-D., M.L., P.K.L., T.R.S.K., G.C., I.S., X.S., W.E.L., O.M.S.).
  • Bers DM; Department of Microbiology, Oslo University Hospital, Norway (B.D.).
  • Sjaastad I; Department of Medical Biochemistry, Institute for Clinical Medicine, University of Oslo, Norway (B.D.).
  • Shen X; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (H.S., V.N.).
  • Louch WE; German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Germany (H.S., S.H., O.J.M., V.N.).
  • Klussmann E; German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Germany (H.S., S.H., O.J.M., V.N.).
  • Sejersted OM; Department of Internal Medicine III, University of Kiel, Kiel, Germany (S.H., O.J.M.).
Circ Res ; 130(1): 27-44, 2022 01 07.
Article em En | MEDLINE | ID: mdl-34814703
BACKGROUND: The sarcoplasmic reticulum (SR) Ca2+-ATPase 2 (SERCA2) mediates Ca2+ reuptake into SR and thereby promotes cardiomyocyte relaxation, whereas the ryanodine receptor (RYR) mediates Ca2+ release from SR and triggers contraction. Ca2+/CaMKII (CaM [calmodulin]-dependent protein kinase II) regulates activities of SERCA2 through phosphorylation of PLN (phospholamban) and RYR through direct phosphorylation. However, the mechanisms for CaMKIIδ anchoring to SERCA2-PLN and RYR and its regulation by local Ca2+ signals remain elusive. The objective of this study was to investigate CaMKIIδ anchoring and regulation at SERCA2-PLN and RYR. METHODS: A role for AKAP18δ (A-kinase anchoring protein 18δ) in CaMKIIδ anchoring and regulation was analyzed by bioinformatics, peptide arrays, cell-permeant peptide technology, immunoprecipitations, pull downs, transfections, immunoblotting, proximity ligation, FRET-based CaMKII activity and ELISA-based assays, whole cell and SR vesicle fluorescence imaging, high-resolution microscopy, adenovirus transduction, adenoassociated virus injection, structural modeling, surface plasmon resonance, and alpha screen technology. RESULTS: Our results show that AKAP18δ anchors and directly regulates CaMKIIδ activity at SERCA2-PLN and RYR, via 2 distinct AKAP18δ regions. An N-terminal region (AKAP18δ-N) inhibited CaMKIIδ through binding of a region homologous to the natural CaMKII inhibitor peptide and the Thr17-PLN region. AKAP18δ-N also bound CaM, introducing a second level of control. Conversely, AKAP18δ-C, which shares homology to neuronal CaMKIIα activator peptide (N2B-s), activated CaMKIIδ by lowering the apparent Ca2+ threshold for kinase activation and inducing CaM trapping. While AKAP18δ-C facilitated faster Ca2+ reuptake by SERCA2 and Ca2+ release through RYR, AKAP18δ-N had opposite effects. We propose a model where the 2 unique AKAP18δ regions fine-tune Ca2+-frequency-dependent activation of CaMKIIδ at SERCA2-PLN and RYR. CONCLUSIONS: AKAP18δ anchors and functionally regulates CaMKII activity at PLN-SERCA2 and RYR, indicating a crucial role of AKAP18δ in regulation of the heartbeat. To our knowledge, this is the first protein shown to enhance CaMKII activity in heart and also the first AKAP (A-kinase anchoring protein) reported to anchor a CaMKII isoform, defining AKAP18δ also as a CaM-KAP.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / Canal de Liberação de Cálcio do Receptor de Rianodina / Proteínas Adaptadoras de Transdução de Sinal / ATPases Transportadoras de Cálcio do Retículo Sarcoplasmático / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina Limite: Animals / Humans Idioma: En Revista: Circ Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Proteínas de Ligação ao Cálcio / Canal de Liberação de Cálcio do Receptor de Rianodina / Proteínas Adaptadoras de Transdução de Sinal / ATPases Transportadoras de Cálcio do Retículo Sarcoplasmático / Proteína Quinase Tipo 2 Dependente de Cálcio-Calmodulina Limite: Animals / Humans Idioma: En Revista: Circ Res Ano de publicação: 2022 Tipo de documento: Article